Codes / ICD10CM / C69.21

C69.21 Malignant neoplasm of right retina

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of right retina

Summary

This condition refers to cancerous growths originating in the right retina, the light-sensitive tissue at the back of the eye responsible for visual processing. It is a rare but serious ocular malignancy that can impair vision and may spread to other parts of the body. The retina’s role in converting light into neural signals makes malignancies here particularly impactful on visual function.

Causes

The exact cause is unknown, but genetic mutations in retinal cells are suspected. Some cases may be linked to environmental factors, though specific triggers are not well-defined. Retinal malignancies often arise from uncontrolled cell growth in the retinal pigment epithelium or photoreceptor layers.

Risk Factors

  • Older age.
  • Prior radiation exposure to the eye or head.
  • Certain genetic syndromes that elevate cancer risk (e.g., hereditary retinoblastoma).
  • A history of other eye malignancies or pre-cancerous conditions.
  • Light eye color may increase susceptibility.

Symptoms

  • Blurred or distorted vision.
  • Seeing flashes of light or floaters.
  • Loss of peripheral vision (tunnel vision).
  • Changes in color perception.
  • Visible dark spots or shadows in the visual field.
  • Pain or discomfort in advanced cases.
  • Sudden vision loss.

Diagnosis

Diagnosis typically involves a thorough eye examination, including dilated retinal imaging, to assess for abnormal growths. Imaging tests like optical coherence tomography (OCT) or fluorescein angiography may be used to evaluate the retina’s structure and blood flow. A biopsy of the affected tissue may be performed to confirm malignancy, often guided by imaging or during surgical intervention.

Treatment Options

Treatment depends on the tumor’s size, location, and extent of spread. Options may include laser therapy to destroy localized tumors, radiation therapy (external beam or plaque) to target the affected area, or surgery to remove the tumor. Systemic therapies, such as chemotherapy or targeted agents, may be considered if the cancer has spread beyond the eye.

Prognosis and Follow-Up

Prognosis varies based on the tumor’s stage, aggressiveness, and response to treatment. Early detection and localized disease generally improve outcomes. Regular follow-up with an ophthalmologist or oncologist is essential to monitor for recurrence or metastasis, which may require additional imaging or interventions.

Complications

Potential complications include permanent vision loss, retinal detachment, glaucoma, or metastasis to other parts of the body (e.g., brain, liver). Advanced cases may lead to eye pain, inflammation, or loss of eye function.

Lifestyle & Prevention

While prevention is limited due to unknown causes, protecting the eyes from excessive UV radiation (e.g., wearing sunglasses) and avoiding unnecessary radiation exposure may reduce risk. Maintaining overall health and regular eye exams can aid in early detection.

When to Seek Professional Help

Seek immediate medical attention for sudden vision changes, persistent floaters, flashes of light, or eye pain, as these may indicate a serious condition requiring prompt evaluation.

Tips for Medical Coders

This code specifies a malignant neoplasm of the right retina. Documentation should clearly indicate the laterality (right) and confirm the diagnosis of a primary retinal malignancy. Ensure the medical record supports the anatomical site and malignancy to justify code assignment.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C69.21 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.